Nemaura Medical Inc. (NASDAQ: NMRD) is a medical technology company developing micro-systems-based wearable diagnostic devices and currently commercializing sugarBEAT(R) and proBEAT(TM). SugarBEAT(R), a CE mark-approved Class IIb medical device, is a non-invasive and flexible continuous glucose monitor (CGM) providing actionable insights derived from real-time glucose measurements and daily glucose trend data, which may help people with diabetes and pre-diabetes better manage, reverse and prevent the onset of diabetes. Nemaura has also submitted a PMA application for sugarBEAT(R) to the U.S. FDA. ProBEAT(TM) comprises a non-invasive glucose monitor and a digital health care subscription service and is due to be launched in the U.S. as a general wellness product. For more information, visit the company’s website at www.NemauraMedical.com.
To watch the recorded presentation, visit https://www.webcaster4.com/Webcast/Page/2019/36552
To view IBN’s virtual coverage of The LD 500, visit https://ibn.fm/TheLD500
About InvestorBrandNetwork’s Virtual Coverage
The InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company, is providing the online investment community with a custom-built portal that includes summaries on each of the publicly traded companies participating virtually at The LD 500. In addition to enabling proficient evaluation of each company via one-click access to market research tools and helpful website links, IBN used social media and syndicated articles to maximize the visibility of this month’s The LD 500.
For more than a decade, IBN has provided real-time coverage for numerous global events and conferences through its various brands, social media accounts and investment newsletters. To further expand visibility of participating companies at these events, and to ensure another successful year for its many event collaborations in 2020, IBN’s syndication partners have extended digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
For more information, please visit https://www.InvestorBrandNetwork.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer
InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
[email protected]